Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
Awakn Opens Fourth European Clinic, Norway Takes Center Stage
Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment
Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022.
The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15 million as of Feb. 14, 2023.
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repetitive, oral microdose psilocybin therapy for Fragile X Syndrome (FXS), a genetic disorder.
Crude Oil Down 1%; SkyWater Technology Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday.
The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P 500 also fell, dropping, 0.63% to 4,111.05.
Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42% to 11,842.10. The S&P 500 also fell, dropping, 0.37% to 4,122.02.
Imax And Cinema XXI To Expand Partnership With Ten New Imax With Laser Locations In Indonesia
New Multi-Theatre Deal to Double IMAX Footprint with Cinema XXI in Indonesia, Marking the Biggest IMAX Agreement for New Systems Since 2020
JAKARTA, Indonesia and NEW YORK, Feb. 14,
Warren Buffett-Backed BYD Eyes $1.2B Battery Plant In China
Warren Buffett-backed Chinese EV maker BYD Co Ltd (OTC:BYDDF) (OTC:BYDDY) is looking to build a new factory for…
Tesla Delivers First Batch Of Model Y, Model 3 Vehicles In Thailand
Tesla Inc. (NASDAQ: TSLA) confirmed the deliveries of the first batch of its Model Y and Model 3 vehicles in Thailand on Tuesday.
Reported Late Monday Feb 13, Chongqing Yazaki Selects BlackBerry To Power Digital LCD Cluster For The Chinese Market
Platform to be deployed within next-generation vehicles from Geely Auto and Dongfeng Liuzhou Auto
WATERLOO, Ontario and SHANGHAI, Feb. 13, 2023 /PRNewswire/ -- BlackBerry
Cullinan Oncology Licenses U.S. Rights To The First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator From Harbour BioMed; Currently In A Phase 1 Clinical Study Being Conducted At U.s. And Australian Sites In Patients With Advanced Solid Tumors
Cullinan Oncology, Inc. (NASDAQ:CGEM) and Harbour BioMed (HKEX: 02142) today announced that Cullinan Oncology has entered into an exclusive license with Harbour BioMed for the development and